These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34235637)

  • 1. Nutritional Ketosis in Parkinson's Disease - a Review of Remaining Questions and Insights.
    Choi A; Hallett M; Ehrlich D
    Neurotherapeutics; 2021 Jul; 18(3):1637-1649. PubMed ID: 34235637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial.
    Phillips MCL; Murtagh DKJ; Gilbertson LJ; Asztely FJS; Lynch CDP
    Mov Disord; 2018 Aug; 33(8):1306-1314. PubMed ID: 30098269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of fasting & ketogenic interventions on the NLRP3 inflammasome: A narrative review.
    Neudorf H; Little JP
    Biomed J; 2024 Feb; 47(1):100677. PubMed ID: 37940045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases.
    Kovács Z; Brunner B; Ari C
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketones and Human Performance.
    Scott JM; Deuster PA
    J Spec Oper Med; 2017; 17(2):112-116. PubMed ID: 28599043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease).
    Włodarek D
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30650523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases.
    Jensen NJ; Wodschow HZ; Nilsson M; Rungby J
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
    Selvaraj S; Kelly DP; Margulies KB
    Circulation; 2020 Jun; 141(22):1800-1812. PubMed ID: 32479196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's disease.
    Choi AH; Delgado M; Chen KY; Chung ST; Courville A; Turner SA; Yang S; Airaghi K; Dustin I; McGurrin P; Wu T; Hallett M; Ehrlich DJ
    BMC Neurol; 2024 Apr; 24(1):106. PubMed ID: 38561682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ketogenic Diet and Alzheimer's Disease.
    Hersant H; Grossberg G
    J Nutr Health Aging; 2022; 26(6):606-614. PubMed ID: 35718870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketogenic-Mimicking Diet as a Therapeutic Modality for Bipolar Disorder: Biomechanistic Rationale and Protocol for a Pilot Clinical Trial.
    Bohnen JLB; Wigstrom TP; Griggs AM; Roytman S; Paalanen RR; Andrews HA; Bohnen NI; Franklin JJH; McInnis MG
    Nutrients; 2023 Jul; 15(13):. PubMed ID: 37447394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the safety and tolerability of a nutritional Formulation in patients with ANgelman Syndrome (FANS): study protocol for a randomized controlled trial.
    Herber DL; Weeber EJ; D'Agostino DP; Duis J
    Trials; 2020 Jan; 21(1):60. PubMed ID: 31918761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional Ketosis with Ketogenic Diets or Exogenous Ketones: Features, Convergence, and Divergence.
    Poff AM; Koutnik AP; Egan B
    Curr Sports Med Rep; 2020 Jul; 19(7):251-259. PubMed ID: 32692060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous ketone supplementation: an emerging tool for physiologists with potential as a metabolic therapy.
    Falkenhain K; Islam H; Little JP
    Exp Physiol; 2023 Feb; 108(2):177-187. PubMed ID: 36533967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review.
    Price S; Ruppar TM
    Appl Nurs Res; 2023 Dec; 74():151745. PubMed ID: 38007248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State of the ketogenic diet(s) in epilepsy.
    Huffman J; Kossoff EH
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):332-40. PubMed ID: 16822355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders.
    Spigoni V; Cinquegrani G; Iannozzi NT; Frigeri G; Maggiolo G; Maggi M; Parello V; Dei Cas A
    Front Endocrinol (Lausanne); 2022; 13():972890. PubMed ID: 36339405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Beta-Hydroxybutyrate Level Is Not Sufficient for the Neuroprotective Effect of Long-Term Ketogenic Diet in an Animal Model of Early Parkinson's Disease. Exploration of Brain and Liver Energy Metabolism Markers.
    Kuter KZ; Olech Ł; Głowacka U; Paleczna M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases.
    Tao Y; Leng SX; Zhang H
    Curr Neuropharmacol; 2022 Nov; 20(12):2303-2319. PubMed ID: 36043794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson's disease.
    Koyuncu H; Fidan V; Toktas H; Binay O; Celik H
    Acta Neurol Belg; 2021 Dec; 121(6):1729-1732. PubMed ID: 32892250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.